XBiotech Announces Dismissal of Class Action Lawsuit in Texas
Oct 11, 2016 12:01 pm UTC| Business
AUSTIN, Texas, Oct. 11, 2016 -- XBiotech Inc. (NASDAQ:XBIT), developer of next-generation True Human™ therapeutic antibodies, today announced that the U.S. District Court for the Western District of Texas granted the...
Q4 Economic Outlook Lowers 2016 Equipment and Software Investment Growth Forecast to -0.5%
Oct 11, 2016 12:01 pm UTC| Business
WASHINGTON, Oct. 11, 2016 -- Investment in equipment and software is expected to contract -0.5 percent in 2016, according to the Q4 update to the 2016 Equipment Leasing Finance U.S. Economic Outlook released today by...
Q4 Economic Outlook Lowers 2016 Equipment and Software Investment Growth Forecast to -0.5%
Oct 11, 2016 12:01 pm UTC| Business
WASHINGTON, Oct. 11, 2016 -- Investment in equipment and software is expected to contract -0.5 percent in 2016, according to the Q4 update to the 2016 Equipment Leasing Finance U.S. Economic Outlook released today by...
Boston, San Francisco Lead the Nation in Active Living
Oct 11, 2016 12:01 pm UTC| Business
WASHINGTON andNASHVILLE, Tenn., Oct. 11, 2016 -- Global well-being improvement leader,Healthways, a Sharecare company, and world-leading management consulting firm, Gallup, have released new research assessing active...
Boston, San Francisco Lead the Nation in Active Living
Oct 11, 2016 12:01 pm UTC| Business
WASHINGTON andNASHVILLE, Tenn., Oct. 11, 2016 -- Global well-being improvement leader,Healthways, a Sharecare company, and world-leading management consulting firm, Gallup, have released new research assessing active...
Oct 11, 2016 12:01 pm UTC| Business
NEWARK, Calif., Oct. 11, 2016 -- CymaBay Therapeutics, Inc. (NASDAQ:CBAY), a clinical-stage biopharmaceutical company focused on developing therapies to treat metabolic diseases with high unmet medical need, today...
Oct 11, 2016 12:01 pm UTC| Business
BOTHELL, Wash., Oct. 11, 2016 -- Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR), a clinical-stage company developing monoclonal antibody therapeutics, today announced the promotion of Larry Benedict to the position of...